CEO Total Pay
$18.2M
FY2025 Summary Compensation, above median
The CEO earned $18.2M in FY2025 against median worker pay of $71,839 · Health Services.
Data updated August 2026
Answer first
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $71,839. Industry placement uses the FY2025 SIC-80 peer cohort (# 10 of 31, 71st percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Health Services companies.
Davita Inc. CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$18,247,106 Top 14% higher than 86% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025
CEO total pay ($18.2M) against pay ratio (254:1) for Davita Inc. (marked) and its 5 closest same-industry peers, against the Health Services industry median on both axes.
Exclusive CEO-to-median-worker bands across 29 complete latest-FY filings in SIC 80. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Davita Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $17.0M | - | $67,535 | 252:1 | - |
| 2022 | $16.7M | -1.7% | $67,488 | 248:1 | -4:1 |
| 2023 | $20.4M | +22% | $68,007 | 300:1 | +52:1 |
| 2024 | $21.8M | +7.1% | $73,047 | 299:1 | -1:1 |
| 2025 | $18.2M | -16% | $71,839 | 254:1 | -45:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 927066, FY2021–2025. Adjacent-year deltas only.
Davita Inc.'s FY2025 ratio 254:1 ranks #10 of 31 Health Services filers (71st percentile). the CEO earned 254× the median employee ($71,839) in FY2025.
Median employee $71,839 (HIGH-MED); STEEP · PEAK stamps put about 254 median-wage years per CEO year.
CEO Total Pay
$18.2M
FY2025 Summary Compensation, above median
Pay Ratio
254:1
Elevated vs. peers
Davita Inc.'s FY2025 ratio 254:1 ranks #10 of 31 Health Services filers (71st percentile). The structured pay-ratio disclosure reports the total without line-item components. Health Services (SIC 80) median ratio is 129:1 across 31 FY2025 filers; Davita Inc.'s $18.2M CEO total is above the $10.2M industry median CEO pay.
Dollar rank #199 and ratio rank #245 split - treat 254:1 as a disclosure, not a fairness score. Open Health Services peers.
Read our methodology - how this data is sourced, computed, and verified. Davita Inc.'s FY2025 ratio 254:1 ranks #10 of 31 Health Services filers (71st percentile).
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $18.2M (Δ $11K lighter vs Davita Inc.); MID · ELITE-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $18.3M (Δ $53K heavier vs Davita Inc.); EXTREME · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $18.3M (Δ $56K heavier vs Davita Inc.); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $18.2M (Δ $61K lighter vs Davita Inc.); MEGA · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
Quest Diagnostics Inc stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Davita Inc.'s STEEP filing.
Davita Inc.'s FY2025 package sits #199 by CEO dollars and #245 by ratio under PEAK · STEEP.
Davita Inc.'s PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.